Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Cerullo

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Current Opinion in Biotechnology|December 25, 2019
Design and application of oncolytic viruses for cancer immunotherapyErkko Ylösmäki, Vincenzo Cerullo
Frontiers in Molecular Medicine|August 1, 2024
Cancer immunotherapies: A hope for the uncurable?Firas Hamdan, Vincenzo Cerullo
Biomedicines|May 27, 2017
Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral VectorsCristian Capasso, Mari Hirvinen, Vincenzo Cerullo
Human Gene Therapy|September 12, 2023
Personalizing Oncolytic VirotherapyFiras Hamdan, Manlio Fusciello, Vincenzo Cerullo
Expert Opinion on Biological Therapy|February 23, 2011
Oncolytic vaccinia virus for the treatment of cancerKilian Guse, Vincenzo Cerullo, Akseli Hemminki
Seminars in Immunology|April 1, 2023
Integrating immunopeptidome analysis for the design and development of cancer vaccinesSara Feola, Jacopo Chiaro, Vincenzo Cerullo
Advances in Experimental Medicine and Biology|February 5, 2021
Viral Nanoparticles: Cancer Vaccines and Immune ModulatorsManlio Fusciello, Erkko Ylösmäki, Vincenzo Cerullo
Current Gene Therapy|November 6, 2007
Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospectsMichael P Seiler, Vincenzo Cerullo, Brendan Lee
Oncoimmunology|November 20, 2012
Oncolytic adenoviruses: A potent form of tumor immunovirotherapyVincenzo Cerullo, Markus Vähä-Koskela, Akseli Hemminki
Viruses|February 20, 2014
The evolution of adenoviral vectors through genetic and chemical surface modificationsCristian Capasso, Mariangela Garofalo, Mari Hirvinen, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Current Opinion in Biotechnology|December 25, 2019
Design and application of oncolytic viruses for cancer immunotherapyErkko Ylösmäki, Vincenzo Cerullo
Frontiers in Molecular Medicine|August 1, 2024
Cancer immunotherapies: A hope for the uncurable?Firas Hamdan, Vincenzo Cerullo
Biomedicines|May 27, 2017
Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral VectorsCristian Capasso, Mari Hirvinen, Vincenzo Cerullo
Human Gene Therapy|September 12, 2023
Personalizing Oncolytic VirotherapyFiras Hamdan, Manlio Fusciello, Vincenzo Cerullo
Expert Opinion on Biological Therapy|February 23, 2011
Oncolytic vaccinia virus for the treatment of cancerKilian Guse, Vincenzo Cerullo, Akseli Hemminki
Seminars in Immunology|April 1, 2023
Integrating immunopeptidome analysis for the design and development of cancer vaccinesSara Feola, Jacopo Chiaro, Vincenzo Cerullo
Advances in Experimental Medicine and Biology|February 5, 2021
Viral Nanoparticles: Cancer Vaccines and Immune ModulatorsManlio Fusciello, Erkko Ylösmäki, Vincenzo Cerullo
Current Gene Therapy|November 6, 2007
Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospectsMichael P Seiler, Vincenzo Cerullo, Brendan Lee
Oncoimmunology|November 20, 2012
Oncolytic adenoviruses: A potent form of tumor immunovirotherapyVincenzo Cerullo, Markus Vähä-Koskela, Akseli Hemminki
Viruses|February 20, 2014
The evolution of adenoviral vectors through genetic and chemical surface modificationsCristian Capasso, Mariangela Garofalo, Mari Hirvinen, et al.
Pageof 14